Antifungal treatment
De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
7
Factors predicting prolonged empirical antifungal treatment in critically ill patients
7
Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis
11
Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study
12
Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
10
Distribution of Candida Species and Their Susceptibility to Antifungal Drugs in Dakar, Senegal
6
Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects
9
Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis
7
<p>Oral Prevalence of <em>Candida</em> Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates</p>
7
Intrastromal antifungal injection as a successful modality of treatment for fungal keratitis: a case series
6
Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review
12
Systematic review and mixed treatment comparison meta analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
11
The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis
7
Outcome of AIDS associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
7
Darling's Disease: A Review
14
Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon
7
Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis
9
<p>Comparison of efficacy and safety of atorvastatin 5% lotion and betamethasone 0.1% lotion in the treatment of scalp seborrheic dermatitis</p>
9
THE ROLE OF CANDIDA ALBICANS ON THE DEVELOPMENT OF STOMATITIS IN PATIENTS WEARING DENTURES
7
<p>Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis</p>
6